Ga naar inhoud
Checked.be
Volledig bedrijfsrapport
Gegenereerd 09-08-2026
Actief BE 0439.621.618NV

BAUSCH & LOMB PHARMA

Stoeterijlaan 156 ·1150 Sint-Pieters-Woluwe, België· 36 jaar actief
Sector: Groothandel (46460)
Conclusie Checked

De berekende faillissementskans van BAUSCH & LOMB PHARMA over 12 maanden bedraagt 0,9% (laag). Het bedrijf is actief sinds 1989 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.

Op basis van Staatsblad- en KBO-gegevens.
Kerncijfers
Actief 36 jaar
Vestigingen 2
Publicaties 19
Faillissementskans (12 mnd) Checked-model v1 · gratis
0,9% Laag
0%0,5%1,5%4%10%≥25%
Regio met hoger faalrisico +Lange historiek −Meerdere vestigingseenheden +

Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?

Risicobeoordeling regelgebaseerd
0 / 100
Laag risico
Vertrouwenssignalen 3 signalen
Lang gevestigd
Opgericht in 1989, 36 jaar actief.
Geen juridische incidenten
Geen faillissement, reorganisatie of voorlopig bewind in het Belgisch Staatsblad.
Administratief in orde
Geen schrappingen door FOD Economie (UBO, jaarrekeningen, adres, activiteit).
Administratieve waarschuwingen 0 gebeurtenissen
Geen administratieve waarschuwingen
Financiële kerncijfers10 NBB-aangiften
Financiën worden verwerkt
NBB heeft 10 aangifte(n) op record voor dit bedrijf, laatste boekjaar 2024 (volledig). De jaarrekening wordt verwerkt.
Aangiften op record
Boekjaar Type Neerlegging Referentie
31-12-2024 volledig 16-07-2025 2025-00304938
31-12-2023 volledig 10-07-2024 2024-00237077
31-12-2022 volledig 07-07-2023 2023-00233574
31-12-2021 volledig 26-07-2022 2022-20267665
31-12-2020 volledig 31-08-2021 2021-65900012
31-12-2019 volledig 28-09-2020 2020-57400076
31-12-2018 volledig 19-06-2019 2019-21600546
31-12-2017 volledig 06-12-2018 2018-74300518
31-12-2016 volledig 18-12-2017 2017-72500117
31-12-2015 volledig 27-10-2016 2016-67000059
Juridische structuur
NACE primair Groothandel(46460)
Rechtsvorm NV(014)
Oprichtingsdatum19-12-1989
StatusActief
Postcode1150
Vestigingseenheden 2 locaties
BAUSCH & LOMB PHARMA
Stoeterijlaan 156, 1150 Sint-Pieters-Woluwede groothandel in medisch-chirurgisch materieel en tandheelkundige instrumenten en benodigdheden
sinds 19902.047.423.837
BAUSCH & LOMB PHARMA
Korte Keppestraat 19, 9320 AalstDiverse administratieve activiteiten ten behoeve van kantoren
sinds 20222.383.016.321
Fysieke vestigingen geregistreerd in de Kruispuntbank van Ondernemingen (KBO).
Vastgoedvoetafdruk Bron: KBO × kadaster

Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.

Vlaanderen 1 (33,3%) Wallonië 1 (33,3%) Brussel 1 (33,3%)
Perceel (capakey) Regio Oppervlakte Gebouwen Hoogte / verd.
41342B0932/00D000 Vlaanderen 1,7 ha 1 · 1.485 m² 5,7 m
25112M0807/00K002 Wallonië 540 m² 1 · 149 m² 17,4 m · 5 verd.
21683D0358/00V056 Brussel 205 m² 1 · 75 m² 12,3 m · 3 verd.
Methodologie
via maatschappelijke zetel: 1 · via vestigingseenheden: 2
3 van 3 percelen met exacte adresmatch; de overige zijn indicatief.
Koppeling op basis van adresgegevens, dit is géén bewijs van eigendom.
Updates 29 gebeurtenissen

Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.

2025
14-08-2025
Staatsblad-akte Bestuurswijziging
v3.2
16-07-2025
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2024 · volledig
2024
18-07-2024
Staatsblad-akte Bestuurswijziging
v3.2
10-07-2024
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2023 · volledig
2023
07-07-2023
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2022 · volledig
2022
07-10-2022
Staatsblad-akte Statutenwijziging
v3.2
20-09-2022
Staatsblad-akte Bestuurswijziging
v3.2
26-07-2022
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2021 · volledig
2021
31-08-2021
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2020 · volledig
2020
28-09-2020
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2019 · volledig
11-03-2020
Staatsblad-akte Bestuurswijziging
v3.2
2019
27-08-2019
Staatsblad-akte Diversen
completed · Peter VAN MELKEBEKE
19-07-2019
Staatsblad-akte Bestuurswijziging
v3.2
27-06-2019
Staatsblad-akte Diversen
proposal · Julie Salteur, Louise-Anne Bertin
19-06-2019
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2018 · volledig
2018
06-12-2018
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2017 · volledig
29-06-2018
Staatsblad-akte Kapitaal & aandelen
v3.2
29-06-2018
Staatsblad-akte Kapitaal & aandelen
v3.2
21-06-2018
Staatsblad-akte Diversen
Substantive delegation · Nathalie Van Landuyt
05-06-2018
Staatsblad-akte Bestuurswijziging
v3.2
03-05-2018
Staatsblad-akte Diversen
Substantive delegation · Nathalie Van Landuyt
30-03-2018
Staatsblad-akte Bestuurswijziging
v3.2
2017
18-12-2017
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2016 · volledig
15-12-2017
Staatsblad-akte Bestuurswijziging
v3.2
08-08-2017
Staatsblad-akte Kapitaal & aandelen
v3.2
2016
12-12-2016
Staatsblad-akte Bestuurswijziging
v3.2
27-10-2016
NBB-neerlegging Jaarrekening neergelegd
boekjaar 2015 · volledig
24-02-2016
Staatsblad-akte Diversen
other · Pierre De Pauw
12-02-2016
Staatsblad-akte Diversen
Substantive delegation · Pierre De Pauw
Belgisch Staatsblad, aktes 19 aktes
Kapitaalverloop · 3
29-06-2018
v3.2
29-06-2018
v3.2
08-08-2017
v3.2
Alle aktes · 19 bijgewerkt 1 jaar geleden
2025
14-08-2025 2 bestuurders benoemd Bestuurswijziging
  • PwC Reviseurs d'Entreprises, Commissaire
  • Loris Guidi, Représentant permanent du commissaire
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "PwC Reviseurs d\u0027Entreprises",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "repr\u00E9sentant permanent du commissaire",
      "person": {
        "rrn": null,
        "name": "Loris Guidi",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
2024
18-07-2024 Eberhard Kuehne benoemd tot bestuurder Bestuurswijziging
  • Eberhard Kuehne, Bestuurder
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Eberhard Kuehne",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Pausch \u0026 Lomb Pharma"
  }
}
2022
07-10-2022 Statutenwijziging Statutenwijziging
Samenvatting: v3.2
Technische details 
{
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "name_change": {
    "new": "",
    "old": "",
    "changed": false
  },
  "seat_change": {
    "changed": true
  },
  "object_change": {
    "changed": false
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "BAUSCH \u0026 LOMB PHARMA"
  },
  "legal_form_change": {
    "new": "Soci\u00E9t\u00E9 anonyme",
    "old": "Soci\u00E9t\u00E9 anonyme",
    "changed": false
  }
}
20-09-2022 2 bestuurders benoemd Bestuurswijziging
  • Loris Guidì, Commissaire
  • Pierre Guibourg, Bestuurder
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "Loris Guid\u00EC",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Pierre Guibourg",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "BAUSCH \u0026 LOMB PHARMA"
  }
}
2020
11-03-2020 Wijziging in het bestuur Bestuurswijziging
Samenvatting: v3.2
Technische details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
2019
27-08-2019 Publicatie in het Belgisch Staatsblad, Diversen Diversen·Peter VAN MELKEBEKE
Samenvatting: completedNotaris: Peter VAN MELKEBEKE · BruxellesKantoor: Berquin Notaires
Technische details 
{
  "stage": "completed",
  "notary": {
    "name": "Peter VAN MELKEBEKE",
    "firm_city": null,
    "firm_name": "Berquin Notaires",
    "office_city": "Bruxelles",
    "is_associated": true
  },
  "act_meta": {
    "language": "fr",
    "pub_date": null,
    "filing_date": "2019-06-17",
    "act_kind_objet": "OPERATION ASSIMILEE A UNE FUSION PAR ABSORPTION DE \u0022BAUSCH \u0026"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-07-31",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma",
        "role": "acquiring",
        "address": "1030 Schaerbeek, Boulevard Lambermont 430",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb",
        "role": "absorbed",
        "address": "1030 Schaerbeek, Boulevard Lambermont 430",
        "is_foreign": false,
        "legal_form": "SPRL",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "719"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2019-01-01",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le patrimoine entier de la soci\u00E9t\u00E9 absorb\u00E9e, sans exception ni r\u00E9serve, est transf\u00E9r\u00E9 \u00E0 titre universel \u00E0 la soci\u00E9t\u00E9 absorbante.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0439.621.618",
    "org_name": "NautaDutilh SPRL",
    "person_name": null,
    "org_rep_person_name": "Louise-Anne Bertin"
  },
  "summary_narrative": "Le 31 juillet 2019, l\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme Bausch \u0026 Lomb Pharma, si\u00E9geant \u00E0 Schaerbeek, a approuv\u00E9 une op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption, par laquelle Bausch \u0026 Lomb Pharma absorbe la soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e Bausch \u0026 Lomb, \u00E9galement situ\u00E9e \u00E0 Schaerbeek. Le transfert porte sur l\u0027ensemble du patrimoine de la soci\u00E9t\u00E9 absorb\u00E9e \u00E0 titre universel, avec effet comptable \u00E0 partir du 1er janvier 2019.",
  "co_filed_documents": [
    "une exp\u00E9dition du proc\u00E8s-verbal",
    "deux procurations"
  ],
  "detected_real_type": "fusion_completed",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
19-07-2019 1 bestuurder benoemd, 1 ontslagnemend Bestuurswijziging
  • PricewaterhouseCoopers Reviseurs d'Entreprises SCRL, Commissaire
  • PricewaterhouseCoopers Reviseurs d'Entreprises SCRL, Commissaire
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "PricewaterhouseCoopers Reviseurs d\u0027Entreprises SCRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "commissaire",
      "person": {
        "rrn": null,
        "name": "PricewaterhouseCoopers Reviseurs d\u0027Entreprises SCRL",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "BAUSCH \u0026 LOMB PHARMA"
  }
}
27-06-2019 Publicatie in het Belgisch Staatsblad, Diversen Diversen·Julie Salteur, Louise-Anne Bertin
Samenvatting: proposalNotaris: Julie Salteur, Louise-Anne Bertin · Bruxelles
Technische details 
{
  "stage": "proposal",
  "notary": {
    "name": "Julie Salteur, Louise-Anne Bertin",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2019-06-27",
    "filing_date": "2019-06-18",
    "act_kind_objet": "D\u00E9p\u00F4t d\u0027un projet commun de fusion par absorption simplifi\u00E9e"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2019-06-17",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "merger_absorption",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma SA",
        "role": "acquiring",
        "address": "Boulevard Lambermont 430, 1030 Schaerbeek",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0461.095.240",
        "name": "Bausch \u0026 Lomb SPRL",
        "role": "absorbed",
        "address": "Boulevard Lambermont 430, 1030 Bruxelles",
        "is_foreign": false,
        "legal_form": "SPRL",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "676, 1\u00B0",
      "719",
      "720 \u00A72"
    ],
    "is_cross_border": false,
    "is_silent_merger": true,
    "balance_basis_date": "2018-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "L\u0027ensemble du patrimoine, tant actif que passif, de Bausch \u0026 Lomb SPRL est transf\u00E9r\u00E9 \u00E0 Bausch \u0026 Lomb Pharma SA par dissolution sans liquidation.",
    "equity_transferred_eur": null,
    "accounting_effective_date": "2019-01-01"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": "0461.095.240",
    "org_name": "NautaDutilh",
    "person_name": null,
    "org_rep_person_name": "Louise-Anne Bertin"
  },
  "summary_narrative": "Les soci\u00E9t\u00E9s Bausch \u0026 Lomb Pharma SA et Bausch \u0026 Lomb SPRL, toutes deux \u00E9tablies \u00E0 Bruxelles, ont conjointement r\u00E9dig\u00E9 un projet commun de fusion par absorption simplifi\u00E9e, conform\u00E9ment aux articles 676, 1\u00B0 et 719 du Code des soci\u00E9t\u00E9s. L\u0027op\u00E9ration pr\u00E9voit la transmission int\u00E9grale du patrimoine de Bausch \u0026 Lomb SPRL \u00E0 Bausch \u0026 Lomb Pharma SA, sans liquidation de la soci\u00E9t\u00E9 absorb\u00E9e, avec effet r\u00E9troactif au 1er janvier 2019. Le projet a \u00E9t\u00E9 d\u00E9pos\u00E9 au greffe du tribunal de commerce de Bruxelles le 18 juin 2019 et publi\u00E9 aux Annexes du Moniteur belge le 27 juin 2019.",
  "co_filed_documents": [
    "le-projet-commun-de-fusion-par-absorption-simplifi\u00E9e-sign\u00E9-le-17-juin-2019"
  ],
  "detected_real_type": "fusion_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
2018
29-06-2018 Verrichting in kapitaal of aandelen Kapitaal & aandelen
Samenvatting: v3.2
Technische details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
29-06-2018 Verrichting in kapitaal of aandelen Kapitaal & aandelen
Samenvatting: v3.2
Technische details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
21-06-2018 Publicatie in het Belgisch Staatsblad, Diversen Diversen·Nathalie Van Landuyt
Samenvatting: Substantive delegationNotaris: Nathalie Van Landuyt · Bruxelles
Technische details 
{
  "stage": null,
  "notary": {
    "name": "Nathalie Van Landuyt",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2018-06-21",
    "filing_date": "2018-06-12",
    "act_kind_objet": "Publication conform\u00E9ment \u00E0 l\u0027article 556 C. Soc."
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2018-05-15",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "substantive_delegation",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma",
        "role": "other",
        "address": "boulevard Lambermont 430 - 1030 Bruxelles",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Thibaut Willems",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Nathalie Van Landuyt",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "NautaDutilh",
        "role": "other",
        "address": "1000 Bruxelles, Chauss\u00E9e de La Hulpe 120",
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556 C. Soc."
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le mandat concerne les formalit\u00E9s de d\u00E9p\u00F4t et de publication du proc\u00E8s-verbal, sans transfert de patrimoine.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nathalie Van Landuyt",
    "org_rep_person_name": null
  },
  "summary_narrative": "Les actionnaires de Bausch \u0026 Lomb Pharma ont d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9, par \u00E9crit, le 15 mai 2018, de nommer Thibaut Willems, Nathalie Van Landuyt et/ou tout avocat du cabinet NautaDutilh, si\u00E9geant \u00E0 Bruxelles, en tant que mandataires sp\u00E9ciaux de la soci\u00E9t\u00E9. Ces mandataires ont pour mission d\u0027accomplir toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du pr\u00E9sent proc\u00E8s-verbal au greffe du tribunal de commerce de Bruxelles et \u00E0 sa publication au Moniteur belge, conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s.",
  "co_filed_documents": [],
  "detected_real_type": "substantive_delegation",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
05-06-2018 1 bestuurder benoemd, 1 ontslagnemend Bestuurswijziging
  • William Norman Woodfield, Bestuurder
  • Linda Ann LaGorga, Bestuurder
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Linda Ann LaGorga",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "William Norman Woodfield",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
03-05-2018 Publicatie in het Belgisch Staatsblad, Diversen Diversen·Nathalie Van Landuyt
Samenvatting: Substantive delegationNotaris: Nathalie Van Landuyt · Bruxelles
Technische details 
{
  "stage": null,
  "notary": {
    "name": "Nathalie Van Landuyt",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": null,
    "filing_date": null,
    "act_kind_objet": "Publication conform\u00E9ment \u00E0 l\u0027article 556 C. Soc."
  },
  "decision": {
    "body": "enig_aandeelhouder_schriftelijk",
    "act_date": "2018-03-01",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "substantive_delegation",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma SA",
        "role": "other",
        "address": "boulevard Lambermont, 430 - 1030 Bruxelles",
        "is_foreign": false,
        "legal_form": "SA",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Fr\u00E9d\u00E9ric Heremans",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "Pierre De Pauw",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "Silke Volckaert",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "Nathalie Van Landuyt",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": null,
        "name": "NautaDutilh",
        "role": "other",
        "address": "1000 Bruxelles, Chauss\u00E9e de La Hulpe 120",
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Le mandat concerne l\u0027accomplissement de toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du pr\u00E9sent proc\u00E8s-verbal au greffe du Tribunal de Commerce et \u00E0 sa publication au Moniteur belge, ainsi que l\u0027approbation et la signature de tout acte ou document relatif \u00E0 ces formalit\u00E9s.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "SA"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Nathalie Van Landuyt",
    "org_rep_person_name": null
  },
  "summary_narrative": "Les actionnaires de Bausch \u0026 Lomb Pharma SA ont d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9, par \u00E9crit, le 1er mars 2018, de d\u00E9signer comme mandataires sp\u00E9ciaux Fr\u00E9d\u00E9ric Heremans, Pierre De Pauw, Silke Volckaert, Nathalie Van Landuyt et/ou tout avocat du cabinet NautaDutilh, pour agir au nom et pour le compte de la soci\u00E9t\u00E9 aux fins de remplir toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du pr\u00E9sent acte au greffe du Tribunal de Commerce et \u00E0 sa publication au Moniteur belge, conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s.",
  "co_filed_documents": [],
  "detected_real_type": "substantive_delegation",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
30-03-2018 1 bestuurder benoemd, 1 ontslagnemend Bestuurswijziging
  • Eberhard Kuehne, Bestuurder
  • Marcin Jedrzejuk, Bestuurder
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Marcin Jedrzejuk",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Eberhard Kuehne",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
2017
15-12-2017 Ling Zeng neemt ontslag als bestuurder Bestuurswijziging
  • Ling Zeng, Bestuurder
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Ling Zeng",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
08-08-2017 Verrichting in kapitaal of aandelen Kapitaal & aandelen
Samenvatting: v3.2
Technische details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma"
  }
}
2016
12-12-2016 2 bestuurders benoemd Bestuurswijziging
  • PricewaterhouseCoopers Reviseurs d'Entreprises SC SCRL, Auditor
  • Pierre Guibourg, Administrator
Samenvatting: v3.2
Technische details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "auditor",
      "person": {
        "rrn": null,
        "name": "PricewaterhouseCoopers Reviseurs d\u0027Entreprises SC SCRL",
        "address": null,
        "birth_date": null
      }
    },
    {
      "kind": "director_in",
      "role": "administrator",
      "person": {
        "rrn": null,
        "name": "Pierre Guibourg",
        "address": null,
        "birth_date": null
      }
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "extractor": "qwen3-30b-a3b"
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "BAUSCH \u0026 LOMB PHARMA"
  }
}
24-02-2016 Publicatie in het Belgisch Staatsblad, Diversen Diversen·Pierre De Pauw
Samenvatting: otherNotaris: Pierre De Pauw · Bruxelles
Technische details 
{
  "stage": null,
  "notary": {
    "name": "Pierre De Pauw",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2016-02-24",
    "filing_date": "2016-01-26",
    "act_kind_objet": ""
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2016-01-26",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "other",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma",
        "role": "other",
        "address": "Boulevard Lambermont 430, 1030 Schaerbeek",
        "is_foreign": false,
        "legal_form": "soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Fr\u00E9d\u00E9ric Heremans",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "Pierre De Pauw",
        "role": "other",
        "address": null,
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      },
      {
        "kbo": null,
        "name": "NautaDutilh",
        "role": "other",
        "address": "1000 Bruxelles, Chauss\u00E9e de La Hulpe 120",
        "is_foreign": false,
        "legal_form": null,
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "Aucun transfert de patrimoine n\u0027est effectu\u00E9. L\u0027acte concerne uniquement la d\u00E9signation de mandataires sp\u00E9ciaux pour le d\u00E9p\u00F4t et la publication du proc\u00E8s-verbal.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Pierre De Pauw",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de Bausch \u0026 Lomb Pharma s\u0027est r\u00E9unie le 26 janvier 2016 et a d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9 de d\u00E9signer Fr\u00E9d\u00E9ric Heremans, Pierre De Pauw et/ou tout avocat du cabinet NautaDutilh comme mandataires sp\u00E9ciaux de la soci\u00E9t\u00E9. Leur mission est d\u0027accomplir toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du pr\u00E9sent acte au greffe du tribunal de commerce et \u00E0 sa publication au Moniteur belge, conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s.",
  "co_filed_documents": [],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": "director_changes"
}
12-02-2016 Publicatie in het Belgisch Staatsblad, Diversen Diversen·Pierre De Pauw
Samenvatting: Substantive delegationNotaris: Pierre De Pauw · Bruxelles
Technische details 
{
  "stage": null,
  "notary": {
    "name": "Pierre De Pauw",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Bruxelles",
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": "2016-02-12",
    "filing_date": "2016-01-26",
    "act_kind_objet": ""
  },
  "decision": {
    "body": "algemene_vergadering",
    "act_date": "2016-01-26",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "substantive_delegation",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0439.621.618",
        "name": "Bausch \u0026 Lomb Pharma",
        "role": "other",
        "address": "Boulevard Lambermont 430, 1030 Bruxelles",
        "is_foreign": false,
        "legal_form": "soci\u00E9t\u00E9 anonyme",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "556"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "Le transfert concerne les pouvoirs de repr\u00E9sentation et de gestion n\u00E9cessaires au d\u00E9p\u00F4t du proc\u00E8s-verbal au greffe du tribunal de commerce et \u00E0 sa publication au Moniteur belge.",
    "equity_transferred_eur": null,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0439.621.618",
    "name_full": "Bausch \u0026 Lomb Pharma",
    "legal_form": "soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Pierre De Pauw",
    "org_rep_person_name": null
  },
  "summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de Bausch \u0026 Lomb Pharma, r\u00E9unie le 26 janvier 2016, a d\u00E9cid\u00E9 \u00E0 l\u0027unanimit\u00E9 de d\u00E9signer Pierre De Pauw, Fr\u00E9d\u00E9ric Heremans et tout avocat du cabinet NautaDutilh \u00E0 Bruxelles comme mandataires sp\u00E9ciaux de la soci\u00E9t\u00E9. Leur mandat, irr\u00E9vocable et valable trois mois, couvre toutes les formalit\u00E9s n\u00E9cessaires au d\u00E9p\u00F4t du proc\u00E8s-verbal au greffe du tribunal de commerce et \u00E0 sa publication au Moniteur belge, conform\u00E9ment \u00E0 l\u0027article 556 du Code des soci\u00E9t\u00E9s.",
  "co_filed_documents": [],
  "detected_real_type": "substantive_delegation",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
Krediet-advies advies per klant en bedrag

Mag deze klant voor een bedrag X op factuur kopen? Vul het bedrag en de betalingstermijn in, je krijgt meteen een GROEN/ORANJE/ROOD-advies, met voorgesteld maximum en concrete voorwaarden.

Gebaseerd op officiële bronnen (NBB, KBO, Staatsblad). Indicatief, geen kredietadvies.
AI due-diligence rapport Checked AI

Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.

Binnenkort beschikbaar
Het rapport wordt opgesteld door ons AI-model bij Anthropic in de VS, op basis van de publieke gegevens van dit dossier. We sturen niets mee dat jou identificeert en bewaren het rapport niet. Indicatief, geen juridisch of investeringsadvies. Zo werkt het
Ondernemingsgegevens (KBO) Kruispuntbank
Activiteiten
Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Groothandel in farmaceutische producten51460
Primaire activiteit gemarkeerd.
Namen & handelsnamen
Officiële naamFR BAUSCH & LOMB PHARMA
Maatschappelijke zetel
Place Alphonse Bosch 19 bus 2
1300 Wavre, België
Officiële gegevens uit de Kruispuntbank van Ondernemingen (KBO). Beschikbaar voor alle geregistreerde ondernemingen.
Vergelijkbare bedrijven Zelfde NACE
ARKOPHARMA BELUX BE 0401.962.852 · Wavre
GlaxoSmithKline Pharmaceuticals, en abrégé GlaxoSmithKline BE 0403.066.474 · Wavre
ABBOTT BE 0403.044.007 · Wavre
EKI'P DENTAL BE 0458.978.462 · Wavre
ORTHOPEDIC BE 0433.672.449 · Wavre
Bron: Belgisch Staatsblad, KBO, NBB · gegenereerd via checked.be · indicatief